Top Markets
Coin of the day
Aziyo Biologics, Inc. Aziyo Biologics, Inc.

Aziyo Biologics, Inc.

AZYO
Classifica tra le azioni #29673
Aziyo Biologics, Inc. (AZYO) operates as a regenerative medicine firm,... Aziyo Biologics, Inc. (AZYO) operates as a regenerative medicine firm, concentrating its efforts on developing advanced medical products. Their primary applications target three key areas: implantable electronic devices and cardiovascular care, orthopedic and spinal repair, and the reconstruction of soft tissues. The company's product portfolio includes CanGaroo, an innovative envelope that incorporates antibiotics, specifically engineered to lower the risk of infection following the surgical implantation of an electronic device. Aziyo also provides a suite of cardiovascular solutions. ProxiCor serves as an intracardiac patch or pledget for repairing heart tissues, while Tyke is designed for neonates and infants to mend pericardial structures. Additionally, VasCure offers a versatile patching material for the repair or reconstruction of peripheral blood vessels, encompassing critical arteries like the carotid, renal, iliac, femoral, and tibial, serving cardiovascular, vascular, and general surgeons. For orthopedic procedures, Aziyo offers human tissue-derived bone allografts such as Fiber VBM, ViBone, and OsteGro V. These products are formulated to protect and preserve the body's natural bone cells. In the realm of soft tissue repair, they feature SimpliDerm, a pre-hydrated human acellular dermal matrix (HADM) developed for the repair or replacement of damaged or insufficient skin and related integumental tissues. Beyond its proprietary product line, Aziyo Biologics extends contract manufacturing services, producing various items for other corporate clients. The company distributes its products to hospitals and other healthcare facilities through a multi-faceted sales approach, utilizing its dedicated direct sales force, strategic commercial partners, and independent sales agents. Founded in 2015, Aziyo Biologics, Inc. maintains its headquarters in Silver Spring, Maryland.
Prezzo delle azioni
$1.39
Ultima sincronizzazione: 2023-10-03
Capitalizzazione di mercato
$20.11M
Variazione (1 giorno)
-3.47%
Variazione (1 anno)
0.00%
Paese
US
Scambia Aziyo Biologics, Inc. (AZYO)

Categoria

Il prezzo AZYO con la capitalizzazione del mercato della B
Aziyo Biologics, Inc. Aziyo Biologics, Inc.
AZYO
$1.39
Capitalizzazione di mercato di Aziyo Biologics, Inc.(AZYO)
Capitalizzazione di mercato: $20.11M
A partire dal August 2026, Aziyo Biologics, Inc. ha una capitalizzazione di mercato pari a $20.11M. Questo rende Aziyo Biologics, Inc. la 29673rd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Aziyo Biologics, Inc. dal 2020 al 2026
AZYO in paragone con la classifica dei più popolari stocks
Il prezzo per AZYO Attivo B Capitalizzazione del mercato a B Risultati
Aziyo Biologics, Inc. Aziyo Biologics, Inc.
$366,760 $20.11M
$5.307T +26,385,478.09%
Aziyo Biologics, Inc. Aziyo Biologics, Inc.
$314,520 $20.11M
$4.551T +22,627,219.10%
Aziyo Biologics, Inc. Aziyo Biologics, Inc.
$287,125 $20.11M
$4.154T +20,656,381.40%
Aziyo Biologics, Inc. Aziyo Biologics, Inc.
$248,019 $20.11M
$3.589T +17,843,006.14%
Aziyo Biologics, Inc. Aziyo Biologics, Inc.
$193,302 $20.11M
$2.797T +13,906,486.77%